Companies / Israel
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Teva Announces Strong Results For 2006
February 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Israeli drugmaker Teva has announced record results for 2006, with sales rising by 60% to reach US$8.4bn. This dynamic performance was driven by the integration of IVAX - which Teva acquired at the beginning of 2006 in a deal worth US$7.8bn - with Q4 sales rising 63% to US$2.3bn, from a figure of US$1.4bn in the same period last year.